Event Date - March 1 2011

Presented By: Dr. Jean Paty, Founder and Chief Scientist and Regulatory Advisor, invivodata, inc.

Original Air Date: March 1, 2011

Dr. Jean Paty will review the scientific and regulatory rationale for developing and validating PRO measures and implementing electronic PRO methods in Phase II clinical trials.  The presentation will review the real-world value of using ePRO early in clinical development, including the practical benefits of justifying study investment to both internal and external audiences.